Rockwell Medical, Inc. Made Big Gain
Rockwell Medical, Inc. (RMTI:NASDAQ) soared at $3.32, representing a gain of 23%. On Wed, May 31, 2023, RMTI:NASDAQ touched a New 2-Week High of $3.32. The stock appeared on our News Catalysts scanner on Mon, May 15, 2023 at 06:22 AM in the 'EARNINGS' category. From Wed, May 17, 2023, the stock recorded 66.67% Up Days and 70.00% Green Days
About Rockwell Medical, Inc. (RMTI:NASDAQ)
Rockwell Medical Inc is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease with its products and services for the treatment of iron deficiency, secondary hyperparathyroidism, and hemodialysis.
Top 10 Gainers:
- SunCar Technology Group Inc Ord (SDA:NASDAQ), 120.88%
- Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ), 114.81%
- Marker Therapeutics, Inc. (MRKR:NASDAQ), 34.85%
- Inventiva S.A. (IVA:NASDAQ), 31.5%
- VIQ Solutions Inc. (VQS:NASDAQ), 28.76%
- Peak Bio Inc Com (PKBO:NASDAQ), 26.41%
- Bright Green Corporation (BGXX:NASDAQ), 24.01%
- Rockwell Medical, Inc. (RMTI:NASDAQ), 22.96%
- Bluejay Diagnostics Inc. (BJDX:NASDAQ), 22.88%
- BYND Cannasoft Enterprises Inc. (BCAN:NASDAQ), 22.59%